Financial reports
10-Q
2024 Q3
Quarterly report
13 Nov 24
10-Q
2024 Q2
Quarterly report
21 Oct 24
NT 10-Q
Notice of late quarterly filing
15 Aug 24
10-Q
2024 Q1
Quarterly report
14 May 24
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
15 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
20 Mar 23
Current reports
8-K
Entry into a Material Definitive Agreement
7 Mar 25
8-K
Entero Therapeutics Appoints Richard Paolone as CEO
14 Feb 25
8-K
Entry into a Material Definitive Agreement
6 Feb 25
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Jan 25
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
27 Nov 24
8-K
Entry into a Material Definitive Agreement
13 Nov 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Sep 24
8-K
Regulation FD Disclosure
10 Sep 24
8-K
Other Events
3 Sep 24
8-K
Changes in Registrant's Certifying Accountant
29 Aug 24
Registration and prospectus
S-3
Shelf registration
26 Jul 24
S-8
Registration of securities for employees
24 Jun 24
424B3
Prospectus supplement
14 Jun 24
S-3
Shelf registration
31 May 24
424B5
Prospectus supplement for primary offering
13 May 24
424B5
Prospectus supplement for primary offering
4 Mar 24
424B3
Prospectus supplement
18 Jan 24
S-3
Shelf registration
8 Jan 24
RW
Registration withdrawal request
28 Dec 23
S-1/A
IPO registration (amended)
27 Dec 23
Proxies
PRER14A
Preliminary revised proxy
17 Jun 24
DEFA14A
Additional proxy soliciting materials
30 May 24
DEFA14A
Additional proxy soliciting materials
18 Mar 24
DEFA14A
Additional proxy soliciting materials
14 Mar 24
DEF 14A
Definitive proxy
13 Nov 23
PRER14A
Preliminary revised proxy
31 Oct 23
PRE 14A
Preliminary proxy
12 Oct 23
DEF 14A
Definitive proxy
15 May 23
DEFA14A
Additional proxy soliciting materials
9 Jan 23
DEF 14A
Definitive proxy
16 Dec 22
Other
EFFECT
Notice of effectiveness
11 Jun 24
EFFECT
Notice of effectiveness
18 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
UPLOAD
Letter from SEC
12 Jan 24
EFFECT
Notice of effectiveness
2 Oct 23
CORRESP
Correspondence with SEC
28 Sep 23
UPLOAD
Letter from SEC
26 Sep 23
EFFECT
Notice of effectiveness
18 Jul 23
CORRESP
Correspondence with SEC
14 Jul 23
CORRESP
Correspondence with SEC
14 Jul 23